Sightic Analytics AB

Sightic Analytics is an AI-driven safety technology company focused on real-time detection of alcohol and drug impairment through advanced eye-analysis algorithms. Founded in 2017, the company has developed proprietary computer-vision and machine-learning capabilities to identify behavioral and physiological indicators of substance-related impairment within seconds—dramatically faster than traditional field sobriety or biological testing. The company operates as a Swedish AB (limited company) with strong Israeli heritage and is positioned at the intersection of public safety, regulatory compliance, and transportation safety.

The company serves two primary markets: law enforcement impairment screening (enabling objective, rapid drug/alcohol detection in ~10 seconds versus 15-60 minutes for traditional methods) and automotive safety through in-cabin driver monitoring. In automotive, Sightic's technology is marketed as an enhancement to existing driver-monitoring systems (DMS) that can detect drowsiness and distraction; Sightic adds substance-impairment detection using the vehicle's existing in-cabin camera infrastructure, requiring no additional sensors. The technology leverages what the company claims is the world's largest naturalistic dataset of impaired-driving behavior, collected through structured research protocols in collaboration with automotive OEMs, encompassing thousands of drivers across diverse demographic groups in controlled high-impairment scenarios.

Commercially, Sightic has demonstrated traction through partnerships with automotive manufacturers (notably Volvo mentioned publicly) and law enforcement agencies. The company received €5 million in funding from the European Innovation Council (EIC) in 2024-2025, a highly competitive grant program that signals international recognition of the technology's potential impact. The software is positioned as hardware-agnostic and integrable with existing in-cabin infrastructure, reducing deployment friction and capital requirements for OEMs and fleet operators seeking to add substance-impairment detection to their safety portfolios.

The market opportunity is substantial: approximately 1.19 million deaths globally per year are attributed to road traffic accidents, with roughly 30-31% involving alcohol and/or drug impairment (including prescription medications, over-the-counter drugs, and controlled substances). In the EU alone, ~20,000 annual road deaths are linked to substance impairment. Regulators in Europe are increasingly mandating advanced in-cabin monitoring for new vehicles, creating a structural tailwind for safety technologies. Sightic's early positioning in a nascent market segment and proprietary dataset give it potential first-mover advantage in automotive OEM integration.